P
US6136848AExpiredUtilityPatentIndex 60

Flavone derivative and medicine comprising the same

Assignee: KOWA COPriority: Oct 4, 1996Filed: Oct 2, 1997Granted: Oct 24, 2000
Est. expiryOct 4, 2016(expired)· nominal 20-yr term from priority
Inventors:ZWAAGSTRA MARIA ELIZABETHZHANG MINGQIANGTIMMERMAN HENKTAMURA MASAHIROWADA YASUSHI
A61P 37/08A61P 9/10A61P 43/00A61P 9/00A61P 27/14A61P 27/02A61P 29/00C07C 311/30C07D 405/14A61P 17/00A61P 1/00C07D 417/12C07D 405/12A61P 11/00A61P 11/06C07D 405/10C07D 311/02
60
PatentIndex Score
5
Cited by
21
References
11
Claims

Abstract

This invention relates to a flavone derivative represented by the formula (1) or a salt thereof, and also to a medicine containing the same. ##STR1## wherein A represents H, halogen, phenyl, naphthyl, a group of the formula (2) in which X is H or halogen, B is --CH═CH--, --CH═N--, --N(R 7 )-- (R 7 : lower alkyl or alkoxyalkyl), --O-- or --S--; W represents a single bond, --CH 2 O-- or --CH═CH--; at least one of R 1 to R 4 represents --COOH, --CN, alkyloxycarbonyl, tetrazolyl or --CONHR 8 (R 8 : H, lower alkyl or phenylsulfonyl), the remainder thereof individually represent H, halogen, --OH, lower alkyl or lower alkoxyl; R 5 represents H, --OH, lower alkoxyl, --O(CH 2 ) m NR 9 R 10 (R 9 ,R 10 : H or lower alkyl, or coupled together with the adjacent N to form a phthalimido group; m: 1-5), or a group of the formula (3) (n: 1-5, l: 2-3; and R 6 represents H, halogen, lower alkyl or lower alkoxyl. A situation where A is H or halogen, W is a single bond and R 5 is H is excluded. The compound (1) has excellent cys-LT 1 receptor antagonism.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A flavone derivative represented by the following formula (1): ##STR70## wherein A represents a hydrogen atom, a halogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, or a group represented by the following formula (2): ##STR71## wherein X represents a hydrogen atom or a halogen atom, and B represents --CH═CH--, --CH--N--, --N(R 7 )-- in which R 7  represents a lower alkyl group or an alkoxyalkyl group, --O-- or --S--, W represents a single bond, --CH 2  O-- or --CH═CH--,   at least one of R 1 , R 2 , R 3  and R 4  represents a carboxyl group, a cyano group, a substituted or unsubstituted alkyloxycarbonyl group, a tetrazolyl group, or --CONHR 8  in which R 8  represents a hydrogen atom, a lower alkyl group or a phenylsulfonyl group, and the remainder thereof may be the same or different and individually represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxyl group,   R 5  represents a hydrogen atom, a hydroxyl group, a substituted or unsubstituted lower alkoxyl group, --O(CH 2 ) m  NR 9  R 10  in which R 9  and R 10  may be the same or different and individually represent a hydrogen atom or a lower alkyl group or are coupled together with the adjacent nitrogen atom to form a phthalimido group, and m stands for a number of 1-5, or a group represented by the following formula (3): ##STR72## wherein n stands for a number of 1-5, l stands for a number of 2-3, and B and X have the same meanings as defined above, and   R 6  represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxyl group, with the proviso that a situation where A is a hydrogen atom or a halogen atom, W is a single bond and R 5  is a hydrogen atom is excluded; or   a salt of said flavone derivative.   
     
     
       2. The compound of claim 1, wherein in the formula (1), A represents a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, or a group represented by the following formula (2): ##STR73## wherein X represents a hydrogen atom or a halogen atom, and B represents --CH═CH--, --CH--N--, --N(R 7 )-- in which R 7  represents a lower alkyl group or an alkoxyalkyl group, --O-- or --S--,   W represents --CH 2  O-- or --CH═CH--,   at least one of R 1 , R 2 , R 3  and R 4  represents a carboxyl group, a cyano group, a substituted or unsubstituted alkyloxycarbonyl group, a tetrazolyl group, or --CONHR 8  in which R 8  represents a hydrogen atom, a lower alkyl group or a phenylsulfonyl group, and the remainder thereof may be the same or different and individually represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxyl group,   R 5  represents a hydrogen atom, a hydroxyl group, a substituted or unsubstituted lower alkoxyl group, --O(CH 2 ) m  NR 9  R 10  in which R 9  and R 10  may be the same or different and individually represent a hydrogen atom or a lower alkyl group or are coupled together with the adjacent nitrogen atom to form a phthalimido group, and m stands for a number of 1-5, or a group represented by the following formula (3): ##STR74## wherein n stands for a number of 1-5, l stands for a number of 2-3, and B and X have the same meanings as defined above, and   R 6  represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxyl group.   
     
     
       3. The compound of claim 1, wherein in the formula (1), A represents a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, or a group represented by the following formula (2): ##STR75## wherein X represents a hydrogen atom or a halogen atom, and B represents --CH═CH--, --CH--N--, --N(R 7 )-- in which R 7  represents a lower alkyl group or an alkoxyalkyl group, --O-- or --S--,   W represents --CH 2  O-- or --CH═CH--,   at least one of R 1 , R 2 , R 3  and R 4  represents a carboxyl group, a cyano group, a substituted or unsubstituted alkyloxycarbonyl group, a tetrazolyl group, or --CONHR 8  in which R 8  represents a hydrogen atom, a lower alkyl group or a phenylsulfonyl group, and the remainder thereof may be the same or different and individually represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxyl group,   R 5  represents a hydrogen atom, a hydroxyl group, a substituted or unsubstituted lower alkoxyl group, or --O(CH 2 ) m  NR 9  R 10  in which R 9  and R 10  may be the same or different and individually represent a hydrogen atom or a lower alkyl group or are coupled together with the adjacent nitrogen atom to form a phthalimido group, and m stands for a number of 1-5, and   R 6  represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxyl group.   
     
     
       4. The compound of claim 1, wherein in the formula (1), A represents a hydrogen atom or a halogen atom,   W represents a single bond,   at least one of R 1 , R 2 , R 3  and R 4  represents a carboxyl group, a cyano group, a substituted or unsubstituted alkyloxycarbonyl group, a tetrazolyl group, or --CONHR 8  in which R 8  represents a hydrogen atom, a lower alkyl group or a phenylsulfonyl group, and the remainder thereof may be the same or different and individually represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxyl group,   R 5  represents a hydroxyl group, a substituted or unsubstituted lower alkoxyl group, --O(CH 2 ) m  NR 9  R 10  in which R 9  and R 10  may be the same or different and individually represent a hydrogen atom or a lower alkyl group or are coupled together with the adjacent nitrogen atom to form a phthalimido group, and m stands for a number of 1-5, or a group represented by the following formula (3): ##STR76## wherein n stands for a number of 1-5, l stands for a number of 2-3, and B and X have the same meanings as defined above, and   R 6  represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxyl group.   
     
     
       5. A medicine comprising as an effective ingredient the compound of any one of claims 1-4. 
     
     
       6. The medicine of claim 5, which is a cys-LT 1  receptor antagonist. 
     
     
       7. The medicine of claim 5, which is a preventive or therapeutic for an allergic disease. 
     
     
       8. The medicine of claim 5, which is a preventive or therapeutic for a disease selected from asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, urticaria, psoriasis, rheumatism, inflammatory colitis, cerebral ischemia or cerebral apoplexy. 
     
     
       9. A medicinal composition comprising the compound of any one of claims 1-4 and a pharmacologically acceptable carrier. 
     
     
       10. A treatment method of an allergic disease, which comprises administering an effective amount of the compound of claim 1. 
     
     
       11. The treatment method of claim 10, wherein said allergic disease is a disease selected from asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, urticaria, psoriasis, rheumatism, inflammatory colitis, cerebral ischemia or cerebral apoplexy.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.